For in-vitro research use only. Not for human consumption.
Survodutide
Survodutide (BI 456906) is a dual-acting peptide targeting both GLP-1 and glucagon receptors. The glucagon component is studied for its effects on hepatic lipid metabolism and energy expenditure, complementing GLP-1-mediated metabolic signaling. This makes it a tool for studying liver-targeted metabolic pathways.
Survodutide definition
Survodutide is a synthetic dual glucagon / GLP-1 receptor agonist peptide. Research models examine its dual-receptor incretin and glucagon-pathway pharmacology in comparison with related compounds in the dual-agonist research family (mazdutide). Research use only. Supplied by Nexus Laboratory with batch-level certificate of analysis documenting HPLC purity, mass spectrometry identity, and endotoxin screening.
No sequence is listed in the current catalog record for this product.
- CAS
- 2805997-46-8
- MW
- ~4450 g/mol
- Sequence
- Not listed
- Half-life
- Not listed
- Formula
- C192H289N47O61
- Purity
- 99.69%
- Form
- Lyophilized powder
- Class
- Dual GLP-1/Glucagon Receptor Agonist
Reconstitution calculator
Estimate vial concentration and aliquot volume from the selected vial mass, solvent volume, and target research amount.
Calculations are for lab planning only and do not replace the product COA, protocol requirements, or qualified professional review. Confirm solvent compatibility before use.
Compound details.
- CAS Number
- 2389736-43-2
- Molecular Weight
- ~4609 g/mol
- Class
- Dual GLP-1 / glucagon agonist
- Receptor targets
- GLP-1R + GCGR
Research context.
Studied in preclinical research models examining dual GLP-1 / glucagon receptor pharmacology, multi-receptor incretin signaling research, and comparator research within the dual-agonist family. Research use only.
Verification standard.
Every Nexus Laboratory batch ships with a Certificate of Analysis documenting HPLC purity (target ≥98%), mass spectrometry identity (expected versus observed mass), and endotoxin screening — verified by third-party laboratory testing and publicly archived. Review Nexus lab verification.
Survodutide is part of the Nexus GLP-1 & Metabolic catalog. GLP-1, amylin, and multi-agonist metabolic research peptides. Each listed variant is priced from the consolidated Nexus catalog and intended for qualified research use only.
TODO-COPY: replace with real compound-specific narrative.
The chemistry.
Dual GLP-1/glucagon receptor agonist peptide (also known as BI 456906)
Storage: Store at -20°C (long term). Refrigerate after reconstitution.
Technical specifications.
- Product Name: Survodutide 10mg
- Classification: Dual GLP-1/Glucagon Receptor Agonist
- Structural Description: Dual GLP-1/glucagon receptor agonist peptide (also known as BI 456906)
- CAS Number: 2805997-46-8
- Molecular Weight: ~4450 g/mol
- Purity: ≥99% (verified by HPLC and Mass Spectrometry)
- Physical Form: Lyophilized (freeze-dried) powder
- Intended Use: In-vitro research use only — not for human consumption
HPLC trace preview.
Related research compounds
Same category, mechanism overlap, and common research stack pairings.
Survodutide research FAQ.
What is Survodutide used for in research?
Survodutide is supplied for controlled in-vitro research workflows in the GLP-1 & Metabolic category. It is not labeled for human or veterinary use.
Is Survodutide HPLC verified?
Survodutide is listed with Nexus lab verification. Current catalog records show 99.69% purity context where batch COA data is available.
Which Survodutide sizes are available?
Current Nexus variants include 10mg.
Does Survodutide include a COA?
Yes. The current Nexus record links Survodutide to batch NEX-SURVODUTIDE-2026-0084.